News Industry News Elixir Medical Corporation Announces Excellent Six-Month Safety and Efficacy Results from the EXCELLA BD Randomized Clinical Trial November 08, 2011
News Industry News Clinical trial comparing Prasurgrel to Clopidogrel following percutaneous coronary intervention is ended early November 08, 2011
News Industry News Cardiovascular Systems' Peripheral and Coronary Data From Six Studies Presented at TCT November 08, 2011
News Industry News Cangrelor provides effective maintenance of platelet inhibition without major bleeding for patients who require bypass surgery November 08, 2011
News Industry News PROMUS Element(TM) Platinum Chromium Stent Demonstrates Excellent Outcomes in Patients With Long Coronary Lesions November 07, 2011
News Industry News Positive Long Term Clinical Data of the Cappella Sideguard(R) Stent System Announced at TCT 2011 November 07, 2011
News Industry News Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System November 07, 2011
News Industry News Medtronic Resolute(R) Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease November 07, 2011
News Industry News First Research Results of Angiomax(R) (Bivalirudin) Versus Heparin in Transcatheter Aortic Valve Interventions Reported at TCT November 07, 2011
News Industry News Economic Study Demonstrates Cost-Effectiveness of Impella Presented at TCT 2011 November 07, 2011
News Industry News Boston Scientific Platinum Chromium ION™ Stent Demonstrates Positive Outcomes in PERSEUS Clinical Program November 07, 2011
News Industry News Boston Scientific Carotid WALLSTENT® Found Safe in Study of High Surgical Risk Patients in Routine Clinical Practice November 07, 2011
News Industry News Axxess Self-Expanding Bifurcation Drug-Eluting Stent Shown To Be Safe And Effective Up To Five Years November 07, 2011
News Industry News Sunshine Heart Announces Results of Its C-Pulse(R) Feasibility Trial at the Transcatheter Cardiovascular Therapeutics Conference November 06, 2011
News Industry News Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System November 06, 2011